-

Global Artificial Intelligence in Medical Imaging Market (2022 to 2026) - Size, Trends & Forecast with Impact of COVID-19 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Artificial Intelligence in Medical Imaging Market: Size, Trends & Forecast with Impact of COVID-19 (2022-2026)" report has been added to ResearchAndMarkets.com's offering.

Artificial intelligence (AI) is a branch of computer science that aims to emulate human intelligence through intelligent systems such as image analysis and speech recognition. Medical imaging is the technique and process of imaging the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues. AI methods excel at automatically recognizing complex patterns in imaging data and providing quantitative, rather than qualitative, assessments of radiographic characteristics.

The global artificial intelligence in medical imaging market can be segmented based on image acquisition technology (X-Ray, CT, MRI, Ultrasound Imaging, and Molecular Imaging); AI technology (Deep Learning and Other AI & Computer Vision); clinical application (Cardiology, Neurology, Breast, Pulmonology, Liver, and Rest of the Body); and end-user (Medical Institutions and Consumer Healthcare Environment).

COVID-19 has a positive effect on market growth. Attempts have also been made to identify various imaging features of chest CT, resulting in increased popularity for AI in the medical imaging market amid the pandemic. However, with COVID-19 cases on the rise across the world, emerging AI technologies are developed to support hospitals in scaling treatment in the second wave. It also highlights the significance of expanding the use of AI and machine learning in imaging, with the dual goals of improving diagnoses and improving clinician well-being and job security.

The global AI in medical imaging market has increased during the years 2019-2021. The projections are made that the market would rise in the next four years i.e. 2022-2026 tremendously. The global AI in medical imaging market is expected to increase due to the increasing burden of chronic diseases, increasing health spending, increasing funding in AI, increasing government expenditure and policy support, etc. Yet the market faces some challenges such as development hurdles, the black-box nature of AI, etc. Moreover, the market growth would succeed by various market trends like increasing diversity in training datasets, detecting multiple diseases from a single image, high image resolution to maximize algorithm performance, etc.

The global AI in the medical imaging market is fragmented. The key players of the global AI in the medical imaging market are IBM (IBM Watson Health), Butterfly Network, Inc., Gauss Surgical, Inc., and Arterys are also profiled with their financial information and respective business strategies.

Market Dynamics

Drivers

  • Increasing Burden of Chronic Diseases
  • Increasing Health Spending
  • Increasing Funding in Artificial Intelligence
  • Technology Upgrades and Innovation
  • Increase in Demand for Medical Imaging
  • Increasing Government Expenditure and Policy Support

Challenges

  • Development Hurdles
  • Complexity in Identifying Business Use Cases for Acquiring Radiology Software
  • Inadequate Availability of Training Data Sets
  • The Black-box Nature of AI

Trends

  • Moving Toward Superhuman Disease Detection
  • Increasing Diversity in Training Datasets
  • Detecting Multiple Diseases from A Single Image
  • High Image Resolution to Maximize Algorithm Performance

Company Coverage:

  • IBM (IBM Watson Health)
  • Butterfly Network, Inc.
  • Gauss Surgical, Inc.
  • Arterys

For more information about this report visit https://www.researchandmarkets.com/r/eq3eya

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Hexabromocyclododecane (CAS 25637-99-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hexabromocyclododecane (CAS 25637-99-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Hexabromocyclododecane provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a v...

Commercial Gas Rice Cookers Market Report 2026: Revenues Set to Reach $2 Billion by 2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Commercial Gas Rice Cookers Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Commercial Gas Rice Cookers Market is experiencing significant growth, evolving from USD 1.28 billion in 2025 to an anticipated USD 2.00 billion by 2032, driven by a CAGR of 6.52%. This market research report provides a comprehensive analysis of the commercial gas rice cooker sector, highlighting key drivers like foodservice efficiency, industria...

Artemisinin Combination Therapy Market to Grow by $194 Million During 2026-2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Artemisinin Combination Therapy Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Artemisinin Combination Therapy (ACT) market exemplifies dynamic growth and promising potential in the treatment of malaria. Expected to increase from USD 386.40 million in 2025 to USD 608.26 million by 2032, supported by a steady CAGR of 6.69%, this market highlights the evolving landscape for modern antimalarial solutions. At the core of AC...
Back to Newsroom